Squamous cell carcinoma often harbors BRAF mutations, and this is of particular importance, since patients with BRAF-mutant anaplastic thyroid carcinoma can benefit from treatment with targeted drugs [19]. This evidence concerns the gene BRAF and squamous cell carcinoma.